
Update on Intravitreal Injectable Drugs and Dry AMD Treatments
Drs. M. Ali Khan, Ajay Kuriyan, and Sarah Read join host Jay Sridhar to discuss recent developments in intravitreal injectable drugs, including 8-mg aflibercept not initially approved by the FDA, the upcoming PDUFA date for on-label bevacizumab, and approaching injections for dry age-related macular degeneration (AMD).
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.